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RESEARCH ARTICLE
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Abstract
Background
Blood product transfusions are associated with increased morbidity and mortality. The pur-
pose of this study was to determine if implementation of a restrictive protocol for packed red
blood cell (PRBC) and fresh frozen plasma (FFP) transfusion safely reduces blood product
utilization and costs in a surgical intensive care unit (SICU).
Study Design
We performed a retrospective, historical control analysis comparing before (PRE) and after
(POST) implementation of a restrictive PRBC/FFP transfusion protocol for SICU patients.
Univariate analysis was utilized to compare patient demographics and blood product trans-
fusion totals between the PRE and POST cohorts. Multivariate logistic regression models
were developed to determine if implementation of the restrictive transfusion protocol is an
independent predictor of adverse outcomes after controlling for age, illness severity, and
total blood products received.
Results
829 total patients were included in the analysis (PRE, n=372; POST, n=457). Despite higher
mean age (56 vs. 52 years, p=0.01) and APACHE II scores (12.5 vs. 11.2, p=0.006), mean
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units transfused per patient were lower for both packed red blood cells (0.7 vs. 1.2, p=0.03)
and fresh frozen plasma (0.3 vs. 1.2, p=0.007) in the POST compared to the PRE cohort, re-
spectively. There was no difference in inpatient mortality between the PRE and POST co-
horts (7.5% vs. 9.2%, p=0.39). There was a decreased risk of urinary tract infections (OR
0.47, 95%CI 0.28-0.80) in the POST cohort after controlling for age, illness severity and
amount of blood products transfused.
Conclusions
Implementation of a restrictive transfusion protocol can effectively reduce blood product uti-
lization in critically ill surgical patients with no increase in morbidity or mortality.
Background
Evidence demonstrates blood product transfusions adversely affect patient outcomes. This is
especially true in trauma and critically ill surgical patients, in whom it is associated with in-
creased morbidity and mortality [1–3]. In fact, randomized controlled trials illustrate worsened
outcomes with packed red blood cell (PRBC) transfusion in certain subsets of ICU populations
[4–5]. These associations have led to the implementation of restrictive policies for transfusion
in many hospitals in an attempt to improve outcomes in ICU patients [6].
Despite the known risks of blood product transfusion, 14 million units of PRBC are trans-
fused annually in the United States [7]. Forty five percent of ICU patients receive blood prod-
uct transfusions, which can increase to 85% depending on the patient’s length of stay [8–10].
In addition, the age of the stored product is associated with worsening outcomes; the average
age of transfused PRBCs in the United States is 17 days old, and 20% of all transfused blood
products are greater than 28 days old [8–10]. In previous studies, blood that was greater than
or equal to 21 days, which is considered old blood, was shown to lead to decreased peripheral
tissue oxygenation [11].
We hypothesized that a restrictive protocol for PRBC and fresh frozen plasma (FFP), when
successfully instituted in a surgical intensive care unit (SICU), could significantly lower blood
product utilization without an adverse effect on morbidity and mortality.
Methods
Research was approved by the University of Florida IRB (IRB#6252011). Informed consent
was not needed as all data was analyzed anonymously.
Protocol implementation
A transfusion protocol with restrictive PRBC and FFP transfusion parameters was created and
implemented in a surgical and trauma intensive care unit (SICU) at UF Health Shands Hospital
at the University of Florida. This unit admits critically ill trauma, acute care general surgery,
vascular, orthopedic and traumatic neurosurgery patients.
Resident physicians and advanced practitioners were allowed to transfuse PRBC and FFP
only if patient parameters were consistent with the restrictive protocol (Figs 1 and 2). Surgical
Critical Care (SCC) attending physicians and fellows (defined as critical care residents by the
Accreditation Council for Graduate Medical Education) could order PRBC or FFP outside the
listed criteria, but required justification and documentation of their reasoning. Nursing staff
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were trained to administer blood products only if consistent with the outlined protocol criteria
as documented by a physician completed written form. Verbal orders for product transfusion
were not allowed, except for emergent circumstances, as deemed by the attending surgeon, crit-
ical care fellow or SCC attending physician. Transfusion of blood products was recorded via
the institution’s electronic medical record system (EPIC; Verona, WI.). Whether or not trans-
fusion was under the auspices of the institutional Massive Transfusion Protocol (MTP) was
also recorded. Our institutional MTP is enacted when there is a need for emergent transfusion
Fig 1. Restrictive transfusion protocol for PRBC.
doi:10.1371/journal.pone.0126895.g001
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in an adult patient, usually presumed to be 10 units of PRBCs or greater. The restrictive proto-
col was not applicable to transfusions performed in patients with confirmed active hemorrhage
and/or during the MTP as these individuals are most often in hemorrhagic shock and therefore
not appropriate for blood product restriction. The restrictive protocol was reinstituted in these
patients once the MTP was no longer active. The units transfused during MTP were not
counted towards the total units given; however, these patients were included once they were
stabilized and could take part in the normal protocol.
Fig 2. Restrictive transfusion protocol for FFP.
doi:10.1371/journal.pone.0126895.g002
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Prior to implementation, the protocol was approved by the department and/or division
chief of all relevant admitting surgical services. These criteria were then circulated to all admit-
ting attending surgeons for review. This was followed by a concerted effort for ongoing educa-
tion targeting surgeons, SICU physicians and advanced practitioners about best practices for
blood product utilization in critically ill patients, including, but not limited to departmental
“Grand Rounds” seminars and other didactic sessions. Additionally, nursing education was
conducted, using a combination of presentations, email notifications and on-line didactic
education.
Data Source and Study Population
The two time periods that were analyzed include the four months following institution of the
protocol (POST; March-June, 2011) as well as a historical control period (PRE; March-June,
2010). Data were obtained from the institutional electronic medical record, including patient
demographics, severity of critical illness, blood product administration, complications and
clinical outcomes. Number of operative procedures was determined based on total cases per-
formed in a dedicated operative suite. For patients included in the study, the number of units
transfused was only calculated if they were currently in the SICU.
Statistical Analysis
Categorical variables were reported as frequencies and percentages and continuous variables
were reported as means with standard deviations. Pearson χ2 test or Fisher’s exact test was
used to test independence between categorical variables as appropriate. Sample size was large
enough for valid application of the central limit theorem; therefore we utilized unpaired t-test
for comparison of continuous variables. Outcomes were determined in a retrospective fashion
using ICD-9 coding from clinical documentation. For variables achieving statistical signifi-
cance with univariate testing, we constructed additional multivariable logistic regression mod-
els for each binary outcome using exposure group (POST vs. PRE) as the main predictor in
order to adjust for age, gender, APACHE II score, ICU LOS, and total amount of blood prod-
ucts transfused. Adjusted odds ratios of having adverse outcome for POST compared to PRE
cohorts were reported along with their 95% confidence intervals (CI). All significance tests
were two-sided, with an α level of 0.05 to denote statistical significance. Statistical analyses
were performed with SAS (v.9.3, Cary, N.C.).
Results
A total of 839 patients were admitted to the SICU over the two time periods. 10 patients that
did not have enough data in their chart to calculate their APACHE II score were excluded, leav-
ing 829 patients for inclusion in the final analysis (n = 457 POST; n = 372 PRE). Univariate
analysis of the PRE and POST cohorts revealed similar patient and clinical demographics, with
the exception of the slightly increased age and APACHE II score in the POST group (both
p<0.05) (Table 1). Admission INR levels, lowest hemoglobin in the first 24 hours of admission,
total number of operative procedures, gender, and MTP activation were not significantly differ-
ent between the two groups (Table 1). The total numbers of combined PRBC and FFP units
transfused during the two time periods were 454 and 881 in the POST and PRE cohort, respec-
tively. The mean per patient units transfused for PRBC (0.7 vs. 1.2, p = 0.03) and FFP (0.3 vs.
1.2, p = 0.007) units were lower in the POST compared to the PRE cohort (Table 2). This repre-
sents a 41% reduction of PRBC and 75% reduction of FFP units transfused per patient, adjusted
for patient volume differences, between the PRE and POST periods. After excluding MTP pa-
tients, univariate analysis suggested a significantly higher rate of transfusion within the first
Successful Implementation of a Transfusion Protocol
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Table 1. Demographics—Pre vs. Post Restrictive Transfusion Protocol.
PRE POST
(n = 372) (n = 457)
Mean SD Mean SD (p)
Age (y) 52.5 (20.3) 56.0 (18.3) 0.01
APACHE II score 11.2 (7.1) 12.5 (7.0) 0.006
Admission PTa 16.1 (7.6) 16.5 (5.1) 0.39
Admission INRb 1.3 (0.6) 1.3 (0.6) 0.17
Lowest Hgb 1st 24 hrsc 10.8 (2.2) 10.5 (2.2) 0.054
Operative proceduresd 1.1 (1.9) 1.3 (1.5) 0.10
(n) (%) (n) (%)
Male gender 228 (61.3) 271 (59.3) 0.56
Massive Transfusion Protocol 15 (4.0) 22 (4.8) 0.59
Abbreviations: APACHE, Acute Physiology and Chronic Health Evaluation; PT, prothrombin time; INR, international normalized ratio; Hgb, hemoglobin;
SD, standard deviation.
All percentages were calculated as column percentages.
a Pre n = 327, Post n = 390;
b Pre n = 326, Post n = 390;
c Pre n = 370, Post n = 456;
d Post n = 456;
doi:10.1371/journal.pone.0126895.t001
Table 2. Patient Outcomes—Pre vs. Post Restrictive Transfusion Protocol.
PRE POST
(Mean) (SD) (Mean) (SD) (p)
Ventilator Days 3.9 10.7 2.9 6.5 0.11
ICU LOS 6.2 13.1 5.5 8.2 0.36
Hospital LOS 11.7 18.1 11.2 12.6 0.65
Units PRBC transfused1 1.2 (4.2) 0.7 (1.8) 0.034
Units FFP transfused1 1.2 (6.2) 0.3 (1.4) 0.007
(n) (%) (n) (%)
Transfusion 1st 24 hrs (non-MTP) 44 11.8 35 7.7 0.04
Complications—Bleeding 12 3.2 21 4.6 0.32
Complications—Pneumonia 6 1.6 9 1.97 0.70
Complications—UTI 41 11.0 29 6.4 0.016
Complications—MI 9 2.4 11 2.4 0.99
Complications—Sepsis 35 9.4 52 11.4 0.36
Complications—PE 6 1.6 9 1.9 0.70
Complications—AKI 13 3.49 23 5.0 0.28
In-hospital mortality 28 7.5 42 9.2 0.39
Abbreviations. ICU, Intensive care unit; LOS, length of stay; PRBC, packed red blood cells; FFP, fresh frozen plasma; MTP, massive transfusion protocol;
UTI, urinary tract infection; MI, myocardial infarction; PE, pulmonary embolus; AKI, acute kidney injury; SD, standard deviation.
1Mean units per patient.
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24 hours of admission to the SICU in the PRE cohort (Table 2). This association remained
statistically significant after controlling for age and APACHE II scores, with a 47% decrease in
odds of transfusion within 24 hours (Table 3). Preventable outcomes were defined as adverse
events that were a direct result of failure to follow best practice measures or established
guidelines.
There was no evidence of significant differences among inpatient outcomes between the
PRE and POST cohorts, including preventable hospital mortality, bleeding, pneumonia, myo-
cardial infarctions, pulmonary embolisms, septicemia, surgical site infections, acute kidney in-
jury, respiratory failure and length of stay between POST and PRE time periods (Table 2).
However, the POST cohort was associated with a significantly decreased rate of urinary tract
infections (Table 2). Multivariate logistic regression analysis confirmed that the implementa-
tion of the restrictive transfusion policy (POST) was independently associated with a decreased
risk of urinary tract infection after controlling for age, APACHE II score, and total amount of
blood products transfused (Table 3).
Discussion
When used properly, blood product transfusion can be lifesaving [12,13]. In addition, there is
no doubt that anemia poses a risk to patient survival; however, in their current storage form,
blood component transfusion does not alleviate this risk and carries its own significant inher-
ent risks [12,13]. We have demonstrated that even in a SICU that does not operate under a
fully ‘closed’model in regards to patient orders, a restrictive protocol for PRBC and FFP trans-
fusion can be implemented and successfully decrease overall blood product utilization. This oc-
curred without an increase in morbidity or mortality, even in the setting of having a larger
patient census and higher risk patients, as suggested by slightly increased ages and mean
APACHE II scores. Both of the aforementioned co-factors are independently associated with
worse outcomes in hospitalized populations [14,15]. Although a direct correlation cannot be
made by our study, there was a significantly decreased rate of urinary tract infections associated
with the implementation of this restrictive transfusion policy. In addition, at a minimal cost for
implementing the protocol, we estimate we could have saved more than $130,000 per year.
It is clear that blood transfusion is associated with increased infections, morbidity and mor-
tality in the surgical and critically ill populations [6]. A recent meta-analysis that reviewed the
Table 3. Multivariate Analysis of early transfusion and urinary tract infection rates.
Transfusion within 1st 24 hours (non-MTP)
Odds Ratio 95% CI p
Restrictive Transfusion Protocol 0.53 0.33–0.86 0.011
APACHE II Score 1.10 0.07–1.14 <0.0001
Urinary Tract Infection
Odds Ratio 95% CI p
Restrictive Transfusion Protocol 0.47 0.28–0.80 0.005
Age 1.028 1.01–1.04 0.0002
APACHE II Score 1.05 1.02–1.09 0.005
Units PRBC Transfused 1.15 1.05–1.25 0.003
Units FFP Transfused 0.90 0.79–1.02 0.09
Abbreviations. RR, relative risk; CI, confidence interval.
Abbreviations. APACHE, Acute Physiology and Chronic Health Evaluation; PRBC, packed red blood cells;
FFP, fresh frozen plasma; CI, confidence interval.
Successful Implementation of a Transfusion Protocol
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efficacy of human blood transfusion in the critically ill revealed that almost all studies (42 of
45) indicate that the risks of liberal PRBC transfusion outweigh the benefits; two of the remain-
ing studies were neutral and the final remaining study demonstrated a benefit to transfusion in
a subgroup of a single retrospective study (elderly patients with an acute myocardial infarction
and a hematocrit<30%) [16]. The same report also determined that 17 of the 18 studies that
appropriately reviewed mortality demonstrated that PRBC transfusion was an independent
predictor of death. Finally, all of the 22 studies that analyzed PRBCs association with nosoco-
mial infection concluded that blood transfusion was an independent risk factor for infection
[9]. Recently, Juffermans et al determined that there was an association between the develop-
ment secondary infections and PRBC transfusions [17].
Multiple reports have demonstrated that the utility of FFP administration is questionable
for minor abnormalities in coagulation parameters [18,19]. In a prospective study, in all pa-
tients transfused with FFP, there was a 0.8% normalization of their INR [20]. There is a general
lack of evidence of any known efficacy of FFP transfusion in clinical scenarios in which FFP are
commonly prescribed [21]. FFP has been associated with a trend toward increasing mortality
and an increased risk of acute lung injury [22].
Importantly for both PRBC and FFP, there are very few, if any, studies that have demon-
strated a benefit from transfusion of these blood products [10,21]. In fact, FFP transfusion is
notoriously unsuccessful in obtaining the goals of the transfusion, which are typically normali-
zation of coagulation test and less bleeding [20,22,23]. However, protocolization can work to
reduce inappropriate blood product transfusion, as has been demonstrated in trauma patients
requiring neurosurgical interventions [24–26]. Previous studies have demonstrated a 75% re-
duction in use of FFP by protocolizing their plasma therapy [24]. Using stricter transfusion
guidelines in septic shock patients, one study was able to show similar 90 day mortality and
rates of ischemic events between higher and lower hemoglobin threshold [27].
The increased rates of UTI seen in this study may be due to multiple reasons. PRBC transfu-
sions have been shown to have an association with the development of nosocomial infections
in the initial phases of sepsis [17]. This may be due to various immunomodulations seen in
transfusion patients including alloimmunization and tolerance induction [8]. These can then
lead to decreased host response to antigens and subsequent infections. However, it is difficult
to determine the relationship between decreased blood product usage and the decreased rate of
UTIs in the POST group. There are multiple confounding variables including the definition
used for UTI, which for our study was based on attending documentation and ICD-9 coding.
Even with all existing evidence about the general lack of benefit to PRBC and FFP transfu-
sions, established physician practice habits can make enactment of best practice measures
very difficult. One study demonstrated that even after all personnel agreed to only use FFP
for agreed upon parameters, only 4% of the FFP ordered subsequent to the agreement appro-
priately met criteria [28]. Therefore, specific methodology in a ‘semi-open’model unit was
needed to reinforce education and maintain enforcement of the protocol. Our approach to
this challenge was to have all attending surgical staff agree that (except in the case of the
MTP) PRBC and FFP could only be ordered at the patient’s bedside after completing the
form. This helped to further reinforce a change in clinical practice habits as well as often giv-
ing the SICU team a chance to communicate with the primary service to discuss the necessity
of the transfusion.
To our knowledge, this is the first study to (1) report the impact of a restrictive protocol that
is designed and implemented exclusively in the ICU setting, and (2) to include both PRBCs
and FFP in the same change in practice. Although significant time and effort were required to
create, educate staff about and apply this restrictive transfusion protocol, very little capital in-
vestment was required to successfully implement the restrictions. Blood products are a limited
Successful Implementation of a Transfusion Protocol
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resource and transfusion of a single unit of PRBC is associated with a 10% increase in hospitali-
zation costs [29].
At our institution, direct hospital costs for a single unit of leukoreduced PRBC and FFP at
the time of the study were $183 and $51, respectively. During the POST time period, 323 PRBC
and 131 FFP units were transfused, as opposed to 447 PRBC and 434 FFP units during the his-
torical control period. Thus, 124 less PRBC units and 303 less FFP units were transfused to pa-
tients during the four month POST period. In addition, this was in the setting of a significantly
greater average patient census than during the control time period. Extrapolated over one year,
a conservative estimate of cost savings would be $130,000. One of the main weaknesses of this
study is our inability to determine specific compliance data as well quality improvement (QI)
data. The data collection sheets were used as part of patient improvement protocol and were re-
quired to be stored and subsequently disposed of in a HIPAA compliant manner (as they were
not official parts of the patients chart) after weekly review by the ICU performance group.
Feedback was given to those physicians who tried to order blood off protocol, as well as nursing
staff who administered the blood ordered off protocol. Future studies should be prospective,
rather than retrospective with historical controls, and collect and determine compliance and
specific QI data.
Conclusions
A protocol for restricting the use of multiple blood products can effectively and safely be insti-
tuted in a surgical intensive care unit, leading to a reduction in PRBC and FFP use in critically
ill patients with no increase in morbidity or mortality. Additionally, restrictive transfusion poli-
cies may have a significant cost savings benefit when implemented in surgical intensive care
unit settings.
Supporting Information
S1 Dataset.
(XLSX)
Acknowledgments
We would like to thank members of University of Florida Blood Bank, including Belinda Man-
ukian, Linda Orsini and Monique Huggins for their assistance with this study. We would also
like thank both Drs. Timothy C. Flynn and David S. Guzick for their administrative support, as
well as Lynn Westoff, MSN, MHA, CCRN, RN for her input.
Author Contributions
Conceived and designed the experiments: BS TO JZ JL RD AR EV LG AC DA HL LL PMMZ
AB FM SB PE. Performed the experiments: BS TO JZ AR EV LG AC DA LL PMMZ AB FM
SB PE. Analyzed the data: BS TO JZ DA HL FM SB PE. Contributed reagents/materials/analy-
sis tools: JZ DA HL SB PE. Wrote the paper: BS TO JZ JL RD AR EV LG AC DA HL LL PM
MZ AB FM SB PE.
References
1. Koch CG, Li L, Sessler DI, Figueroa P, Hoeltge GA, Mihaljevic T, et al. Duration of red-cell storage and
complications after cardiac surgery. N Engl J Med. 2008; 358(12): 1229–1239. doi: 10.1056/
NEJMoa070403 PMID: 18354101
Successful Implementation of a Transfusion Protocol
PLOS ONE | DOI:10.1371/journal.pone.0126895 May 26, 2015 9 / 11
2. RobinsonWP 3rd, Ahn J, Stiffler A, Rutherford EJ, Hurd H, Zarzaur BL, et al. Blood transfusion is an in-
dependent predictor of increased mortality in nonoperatively managed blunt hepatic and splenic inju-
ries. J Trauma. 2005; 58(3): 437–444; discussion 444–5. PMID: 15761334
3. Taylor RW, Manganaro L, O'Brien J, Trottier SJ, Parkar N, Veremakis C. Impact of allogenic packed
red blood cell transfusion on nosocomial infection rates in the critically ill patient. Crit Care Med. 2002;
30(10): 2249–2254. PMID: 12394952
4. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Paqliarello G, et al. A multicenter, random-
ized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in
Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999; 340(13): 409–
417.
5. Hajjar LA, Vincent JL, Galas FR, Nakamura RE, Silva CM, Santos MH, et al. Transfusion requirements
after cardiac surgery: the TRACS randomized controlled trial. JAMA. 2010; 304(14): 1559–1567. doi:
10.1001/jama.2010.1446 PMID: 20940381
6. Napolitano LM, Kurek S, Luchette FA, Anderson GL, Bard MR, Bromberg W, et al. Clinical practice
guideline: red blood cell transfusion in adult trauma and critical care. J Trauma. 2009; 67(6): 1439–
1442. doi: 10.1097/TA.0b013e3181ba7074 PMID: 20009700
7. National Blood Data Resource Center. Comprehensive report on blood collection and transfusion in the
United States. National Blood Data Resource Center. 2001. Bethesda, MD.
8. Raghavan M, Marik PE. Anemia, allogenic blood transfusion, and immunomodulation in the critically ill.
Chest. 2005; 127(1): 295–307. PMID: 15653997
9. Marik PE, Corwin HL. Efficacy of red blood cell transfusion in the critically ill: a systematic review of the
literature. Crit Care Med. 2008; 36(11): 3134.
10. Gerber DR. Transfusion of packed red blood cells in patients with ischemic heart disease. Crit Care
Med. 2008; 36(4): 1068–1074. doi: 10.1097/CCM.0b013e318169251f PMID: 18379229
11. Kiraly LN, Underwood S, Differding JA, Schreiber MA. Transfusion of aged packed red blood cells re-
sults in decreased tissue oxygenation in critically injured trauma patients. J Trauma. 2009; 67(1): 29–
32. doi: 10.1097/TA.0b013e3181af6a8c PMID: 19590304
12. Hebert PC, McDonald BJ, Tinmouth A. Overview of transfusion practices in perioperative and critical
care. Vox Sang. 2004; 87 Suppl 2: 209–217. PMID: 15209919
13. Corwin HL, Carson JL. Blood transfusion—when is more really less? N Engl J Med. 2007; 356(16):
1667–9. PMID: 17442910
14. Qiao Q, Lu G, Li M, Shen Y, Xu D. Prediction of outcome in critically ill elderly patients using APACHE II
and SOFA scores. J Int Med Res. 2012; 40(3): 1114–1121. PMID: 22906285
15. Mica L, Rufibach K, Keel M, Trentz O. The risk of early mortality of polytrauma patients associated to
ISS, NISS, APACHE II values and prothrombin time. J TraumaManag Outcomes. 2013; 7: 6. doi: 10.
1186/1752-2897-7-6 PMID: 23705945
16. WuWC, Rathore SS, Wang Y, Radford MJ, Krumholz HM. Blood Transfusion in elderly patients with
acute myocardial infarction. N Eng J Med. 2001; 345(17): 1230–6. PMID: 11680442
17. Juffermans NP, Prins DJ, Vlaar AP, Nieuwland R, Binnekade JM. Transfusion-related risk of secondary
bacterial infections in sepsis patients: a retrospective cohort study. Shock. 2011; 35(4): 355–9. doi: 10.
1097/SHK.0b013e3182086094 PMID: 21192282
18. Stanworth SJ, Walsh TS, Prescott RJ, Lee RJ, Watson DM, Wyncoll D, et al. A national study of plasma
use in critical care: clinical indications, dose and effect on prothrombin time. Crit Care. 2011; 15(2):
R108. doi: 10.1186/cc10129 PMID: 21466676
19. Tinmouth AT, McIntyre L. The conundrum of persistent inappropriate use of frozen plasma. Crit Care.
2011; 15(3): 160. doi: 10.1186/cc10215 PMID: 21635704
20. Abdel-Wahab OI, Healy B, Dzik WH. Effect of fresh-frozen plasma transfusion on prothrombin time and
bleeding in patients with mild coagulation abnormalities. Transfusion. 2006; 46(8): 1279–1285. PMID:
16934060
21. Tavares M, DiQuattro P, Nolette N, Conti G, Sweeney J. Reduction in plasma transfusion after enforce-
ment of transfusion guidelines. Transfusion. 2011; 51(4): 754–761. doi: 10.1111/j.1537-2995.2010.
02900.x PMID: 20946197
22. Murad MH, Stubbs JR, Gandhi MJ, Wang AT, Paul A, Erwin PJ, et al. The effect of plasma transfusion
on morbidity and mortality: a systematic review and meta-analysis. Transfusion. 2010; 50(6): 1370–
1383. doi: 10.1111/j.1537-2995.2010.02630.x PMID: 20345563
23. Stanworth SJ, Brunskill SJ, Hyde CJ, McClelland DB, Murphy MF. Is fresh frozen plasma clinically ef-
fective? A systematic review of randomized controlled trials. Br J Haematol; 2004; 126(1): 139–152.
PMID: 15198745
Successful Implementation of a Transfusion Protocol
PLOS ONE | DOI:10.1371/journal.pone.0126895 May 26, 2015 10 / 11
24. Matevosyan K, Madden C, Barnett SL, Beshay JE, Rutherford C, Sarode R. Coagulation factor levels
in neurosurgical patients with mild prolongation of prothrombin time: effect on plasma transfusion thera-
py. J Neurosurg. 2011; 114(1): 3–7. doi: 10.3171/2010.7.JNS091699 PMID: 20815699
25. Davis JW, Davis IC, Bennink LD, Hysell SE, Curtis BV, Kaups KL, et al. Placement of intracranial pres-
sure monitors: are "normal" coagulation parameters necessary? J Trauma. 2004; 57(6): 1173–7.
PMID: 15625446
26. Bauer DF, McGwin G Jr., Melton SM, George RL, Markert JM. The relationship between INR and devel-
opment of hemorrhage with placement of ventriculostomy. J Trauma. 2011; 70(5): 1112–7. doi: 10.
1097/TA.0b013e3181e7c2ae PMID: 20805772
27. Holst LB, Haase N, Wetterslev J, Wernerman J, Guttormsen AB, Karlsson S, et al. Lower versus higher
hemoglobin threshold for transfusion in septic shock. N Engl J Med. 2014; 371(15): 1381–1391. doi:
10.1056/NEJMoa1406617 PMID: 25270275
28. Pita-Ramirez L, Cabrera Carbajal BE, Ortega Zavala C. [Reasons for fresh frozen plasma transfusion
in a general hospital]. Rev Invest Clin. 1999; 51(2): 89–92. PMID: 10410587
29. Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angelini GD. Increased mortality, postopera-
tive morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation.
2007; 116(22): 2544–2552. PMID: 17998460
Successful Implementation of a Transfusion Protocol
PLOS ONE | DOI:10.1371/journal.pone.0126895 May 26, 2015 11 / 11
